A preclinical evaluation of antimycin a as a potential antilung cancer stem cell agent.
Yeh CT, Su CL, Huang CY, Lin JK, Lee WH, Chang PM, Kuo YL, Liu YW, Wang LS, Wu CH, Shieh YS, Jan YH, Chuang YJ, Hsiao M, Wu AT.
Yeh CT, et al.
Evid Based Complement Alternat Med. 2013;2013:910451. doi: 10.1155/2013/910451. Epub 2013 Jun 11.
Evid Based Complement Alternat Med. 2013.
PMID: 23840269
Free PMC article.